Results 141 to 150 of about 4,599 (158)

Neuroprotective actions of deferiprone in cultured cortical neurones and SHSY‐5Y cells

Journal of Neurochemistry, 2008
Paul Thomas Francis, Robert J Williams, Robert Hider   +2 more
exaly  

Deferiprone

Reactions Weekly, 2011
openaire   +1 more source

Reduction of body iron stores to normal range levels in thalassaemia by using a deferiprone/deferoxamine combination and their maintenance thereafter by deferiprone monotherapy

European Journal of Haematology, 2010
George J Kontoghiorghes, Marios Kleanthous   +1 more
exaly  

Deferiprone therapy for transfusional iron overload

Best Practice and Research in Clinical Haematology, 2005
A VÍCTOR Hoffbrand
exaly  

Efficacy and safety of deferiprone for the treatment of pantothenate kinase-associated neurodegeneration (PKAN) and neurodegeneration with brain iron accumulation (NBIA): Results from a four years follow-up

Parkinsonism and Related Disorders, 2014
Gian Luca Forni, Raffaella Origa, Giovanni Cossu   +2 more
exaly  

Deferiprone

Inpharma Weekly, 1998
openaire   +1 more source

Deferiprone for the treatment of Friedreich's ataxia

Journal of Neurochemistry, 2013
Massimo Pandolfo
exaly  

Sequential Alternating Deferiprone And Deferoxamine Treatment Compared To Deferiprone Monotherapy: Main Findings And Clinical Follow-Up Of A Large Multicenter Randomized Clinical Trial In -Thalassemia Major Patients

Hemoglobin, 2011
Alessandro Morabito, Christian Gluud, Aurelio Maggio   +2 more
exaly  

Deferiprone

Drugs, 1999
Julia A. Barman Balfour, Rachel H. Foster   +1 more
openaire   +1 more source

Clinical Experience With Deferiprone Treatment for Friedreich Ataxia

Journal of Child Neurology, 2016
Sharon Hassin-Baer, Ioav Cabantchik
exaly